External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers.
Luca CindoloRiccardo BertoloAndrea MinerviniFrancesco SessaGianluca MutoPierluigi BoveMatteo VittoriGiorgio BozziniPietro CastellanFilippo MugaveroMario FalsaperlaLuigi SchipsAntonio CeliaMaida BadaAngelo PorrecaAntonio PastoreYazan Al SalhiMarco GiampaoliGiovanni NovellaRiccardo RizzettoNicoló TrabacchinGuglielmo ManticaGiovannalberto PiniRiccardo LombardoAndrea TubaroAlessandro AntonelliCosimo De NunzioPublished in: World journal of urology (2020)
We confirmed that the Cormio nomogram can be used to predict the risk of PCa in patients at increased risk. Implementation of the nomogram in clinical practice will better define its role in the patient's counselling before prostate biopsy.